1.Current progress of research on pharmacologic actions of salvianolic acid B.
Wei CAO ; Xiao-Wen GUO ; Hu-Zhan ZHENG ; De-Ping LI ; Guan-Bo JIA ; Jie WANG
Chinese journal of integrative medicine 2012;18(4):316-320
As one of the main water-soluble composites of Radix Salviae, salvianolic acid B is a phenolic acid ingredient of the Chinese drug, which is rich content in the herb and has strong pharmaceutical activity. It is used to treat cardiocerebral vascular diseases, antagonize hepatic/renal fibrosis, prevent cancer, and promote stem cell proliferation and differentiation. In the researches of its acting mechanisms, rather deepened studies have been carried out for its application on cardiocerebral vascular diseases, but that for others are rather fewer.
Benzofurans
;
pharmacology
;
therapeutic use
;
Biomedical Research
;
trends
;
Disease
;
Humans
;
Medicine, Chinese Traditional
;
trends
;
Stem Cells
;
drug effects
;
Ventricular Remodeling
;
drug effects
2.Sulfuretin protects against cytokine-induced beta-cell damage and prevents streptozotocin-induced diabetes.
Mi Young SONG ; Gil Saeng JEONG ; Kang Beom KWON ; Sun O KA ; Hyun Young JANG ; Jin Woo PARK ; Youn Chul KIM ; Byung Hyun PARK
Experimental & Molecular Medicine 2010;42(9):628-638
NF-kappaB activation has been implicated as a key signaling mechanism for pancreatic beta-cell damage. Sulfuretin is one of the main flavonoids produced by Rhus verniciflua, which is reported to inhibit the inflammatory response by suppressing the NF-kappaB pathway. Therefore, we isolated sulfuretin from Rhus verniciflua and evaluated if sulfuretin could inhibit cytokine- or streptozotocin-induced beta-cell damage. Rat insulinoma RINm5F cells and isolated rat islets were treated with IL-1beta and IFN-gamma to induce cytotoxicity. Incubation of cells and islets with sulfuretin resulted in a significant reduction of cytokine-induced NF-kappaB activation and its downstream events, iNOS expression, and nitric oxide production. The cytotoxic effects of cytokines were completely abolished when cells or islets were pretreated with sulfuretin. The protective effect of sulfuretin was further demonstrated by normal insulin secretion of cytokine-treated islets in response to glucose. Treatment of mice with streptozotocin resulted in hyperglycemia and hypoinsulinemia, which was further evidenced by immunohistochemical staining of islets. However, the diabetogenic effects of streptozotocin were completely prevented when mice were pretreated with sulfuretin. The anti-diabetogenic effects of sulfuretin were also mediated by suppression of NF-kappaB activation. Collectively, these results indicate that sulfuretin may have therapeutic value in preventing beta-cell damage.
Animals
;
Benzofurans/*pharmacology/therapeutic use
;
Cell Line
;
Cytokines/*adverse effects
;
Diabetes Mellitus, Experimental/drug therapy/*prevention & control
;
Flavonoids/pharmacology/therapeutic use
;
Hypoglycemic Agents/pharmacology/therapeutic use
;
Insulin-Secreting Cells/*drug effects
;
Male
;
Mice
;
Mice, Inbred ICR
;
NF-kappa B/*metabolism
;
Rats
;
Rats, Sprague-Dawley
;
Rhus/chemistry
3.Progress on research of salviae and salvianolic acid B in treating myocardial infarction with myocardial cell orientating differentiation of bone marrow mesenchymal stem cell.
Shi-long WANG ; Yuan LIN ; Ze-yao TANG
Chinese Journal of Integrated Traditional and Western Medicine 2010;30(12):1334-1337
Animals
;
Benzofurans
;
pharmacology
;
therapeutic use
;
Bone Marrow Cells
;
cytology
;
Cell Differentiation
;
drug effects
;
Drugs, Chinese Herbal
;
pharmacology
;
therapeutic use
;
Humans
;
Mesenchymal Stem Cell Transplantation
;
methods
;
Mesenchymal Stromal Cells
;
cytology
;
Myocardial Infarction
;
drug therapy
;
therapy
;
Myocytes, Cardiac
;
cytology
;
Phytotherapy
;
Salvia miltiorrhiza
;
chemistry
4.Antioxidant effect of salvianolic acid B on hippocampal CA1 neurons in mice with cerebral ischemia and reperfusion injury.
Yu-feng JIANG ; Zhi-qin LIU ; Wei CUI ; Wen-tong ZHANG ; Jia-pei GONG ; Xi-mei WANG ; Ying ZHANG ; Mei-juan YANG
Chinese journal of integrative medicine 2015;21(7):516-522
OBJETIVETo investigate the neuroprotective effects and underlying mechanisms of salvianolic acid B (Sal B) extracted from Salvia miltiorrhiza on hippocampal CA1 neurons in mice with cerebral ischemia reperfusion injury.
METHODSForty male National Institute of Health (NIH) mice were randomly divided into 4 groups with 10 animals each, including the sham group, the model group, the SalB group (SalB 22.5 mg/kg) and the nimodipine (Nim) group (Nim 1 mg/kg). A mouse model of cerebral ischemia and reperfusion injury was established by bilateral carotid artery occlusion for 30 min followed by 24-h reperfusion. The malondialdehyde (MDA) content, the nitric oxide synthase (NOS) activity, the superoxide dismutase (SOD) activity and total antioxidant capability (T-AOC) of the pallium were determined by biochemistry methods. The morphologic changes and Bcl-2 and Bax protein expression in hippocampal CA1 neurons were observed by using hematoxylineosin staining and immunohistochemistry staining, respectively.
RESULTSIn the SalB group, the MDA content and the NOS activity of the pallium in cerebral ischemia-reperfusion mice significantly decreased and the SOD activity and the T-AOC significantly increased, as compared with the model group (P<0.05 or P<0.01). The SalB treatment also rescued neuronal loss (P<0.01) in the hippocampal CA1 region, strongly promoted Bcl-2 protein expression (P<0.01) and inhibited Bax protein expression (P<0.05).
CONCLUSIONSSalB increases the level of antioxidant substances and decreases free radicals production. Moreover, it also improves Bcl-2 expression and reduces Bax expression. SalB may exert the neuroprotective effect through mitochondria-dependent pathway on hippocampal CA1 neurons in mice with cerebral ischemia and reperfusion injury and suggested that SalB represents a promising candidate for the prevention and treatment of ischemic cerebrovascular disease.
Animals ; Antioxidants ; pharmacology ; therapeutic use ; Benzofurans ; chemistry ; pharmacology ; therapeutic use ; Brain Ischemia ; complications ; drug therapy ; CA1 Region, Hippocampal ; pathology ; Cell Count ; Immunohistochemistry ; Male ; Malondialdehyde ; metabolism ; Mice ; Neurons ; drug effects ; pathology ; Nitric Oxide Synthase ; metabolism ; Reperfusion Injury ; complications ; drug therapy ; Superoxide Dismutase ; metabolism ; bcl-2-Associated X Protein ; metabolism